ARTICLE | Clinical News
Vilazodone: Phase III data
June 8, 2009 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase III trial (CLDA-07-DP-02) in 481 patients showed that oral vilazodone met the primary endpoint of a significant improvement in MADRS scores from baseline ...